Take the next step

Ask your healthcare provider if one of these
treatment options is right for you.

Tap to see IMPORTANT SAFETY INFORMATION, including an important warning on worsening of hepatitis B infection.
SWIPE FOR OPTIONS  

APPROVED 2015

WHAT IS GENVOYA®?

GENVOYA is a 1-pill, once-a-day prescription medicine used to treat HIV-1 in people 12 years and older who weigh at least 77 pounds. It can either be used in people who are starting HIV-1 treatment and have never taken HIV-1 medicines before, or people who are replacing their current HIV-1 medicines and whose healthcare provider determines they meet certain requirements. These include having an undetectable viral load (less than 50 copies/mL) for 6 months or more on their current HIV-1 treatment. GENVOYA combines 4 medicines into 1 pill taken once a day with food. GENVOYA is a complete HIV-1 treatment and should not be used with other HIV-1 medicines.

GENVOYA does not cure HIV-1 infection or AIDS. To control HIV-1 infection and decrease HIV-related illnesses, you must keep taking GENVOYA. Ask your healthcare provider if you have questions about how to reduce the risk of passing HIV-1 to others. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them.

IMPORTANT SAFETY INFORMATION FOR GENVOYA

What is the most important information I should know about GENVOYA?

GENVOYA may cause serious side effects:

  • Worsening of hepatitis B (HBV) infection. GENVOYA is not approved to treat HBV. If you have both HIV-1 and HBV and stop taking GENVOYA, your HBV may suddenly get worse. Do not stop taking GENVOYA without first talking to your healthcare provider, as they will need to monitor your health.

Who should not take GENVOYA?

Do not take GENVOYA if you take:

  • Certain prescription medicines for other conditions. It is important to ask your healthcare provider or pharmacist about medicines that should not be taken with GENVOYA. Do not start a new medicine without telling your healthcare provider.
  • The herbal supplement St. John’s wort.
  • Any other medicines to treat HIV-1 infection.

What are the other possible side effects of GENVOYA?

Serious side effects of GENVOYA may also include:

  • Changes in your immune system. Your immune system may get stronger and begin to fight infections. Tell your healthcare provider if you have any new symptoms after you start taking GENVOYA.
  • Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. If you develop new or worse kidney problems, they may tell you to stop taking GENVOYA.
  • Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat.
  • Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain.

The most common side effect of GENVOYA is nausea. Tell your healthcare provider if you have any side effects that bother you or don’t go away.

What should I tell my healthcare provider before taking GENVOYA?

  • All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney or liver problems, including hepatitis virus infection.
  • All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Other medicines may affect how GENVOYA works. Keep a list of all your medicines and show it to your healthcare provider and pharmacist. Ask your healthcare provider if it is safe to take GENVOYA with all of your other medicines.
  • If you take antacids. Take antacids at least 2 hours before or after you take GENVOYA.
  • If you are pregnant or plan to become pregnant. It is not known if GENVOYA can harm your unborn baby. Tell your healthcare provider if you become pregnant while taking GENVOYA.
  • If you are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed. HIV-1 can be passed to the baby in breast milk.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call 1-800-FDA-1088.1-800-FDA-1088.

Please click here for full Prescribing Information, including Patient Information with important warnings for GENVOYA.

Please click for full Prescribing Information for GENVOYA, DESCOVY, TYBOST, and VITEKTA, including Patient Information with important warnings.

GENVOYA contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide), VITEKTA (elvitegravir), and TYBOST (cobicistat).

GENVOYA contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide), VITEKTA (elvitegravir), and TYBOST (cobicistat).
ODEFSEY contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide) and EDURANT (rilpivirine).
DESCOVY contains tenofovir alafenamide plus the medicine in EMTRIVA (emtricitabine).
STRIBILD contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate), VITEKTA (elvitegravir), and TYBOST (cobicistat).
COMPLERA contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate) and EDURANT (rilpivirine).
TRUVADA contains the medicines in EMTRIVA (emtricitabine) and VIREAD (tenofovir disoproxil fumarate).

 

See full Prescribing Information for COMPLERA, DESCOVY, EMTRIVA, GENVOYA, ODEFSEY, STRIBILD, TRUVADA, TYBOST, VIREAD, and VITEKTA,
including Patient Information with important warnings.

  SWIPE FOR OPTIONS  

APPROVED 2016

WHAT IS ODEFSEY®?

ODEFSEY is a 1-pill, once-a-day prescription medicine used to treat HIV-1 in people 12 years and older. It can either be used in people who are starting HIV-1 treatment, have never taken HIV-1 medicines before, and have an amount of HIV-1 in their blood (“viral load”) that is no more than 100,000 copies/mL; or in people who are replacing their current HIV-1 medicines and whose healthcare provider determines they meet certain requirements. These include having an undetectable viral load (less than 50 copies/mL) for 6 months or more on their current HIV-1 treatment. ODEFSEY combines 3 medicines into 1 pill taken once a day with a meal. ODEFSEY is a complete HIV-1 treatment and should not be used with other HIV-1 medicines.

ODEFSEY does not cure HIV-1 infection or AIDS. To control HIV-1 infection and decrease HIV-related illnesses, you must keep taking ODEFSEY. Ask your healthcare provider if you have questions about how to reduce the risk of passing HIV-1 to others. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them.

IMPORTANT SAFETY INFORMATION FOR ODEFSEY

What is the most important information I should know about ODEFSEY?

ODEFSEY may cause serious side effects:

  • Worsening of hepatitis B (HBV) infection. ODEFSEY is not approved to treat HBV. If you have both HIV-1 and HBV and stop taking ODEFSEY, your HBV may suddenly get worse. Do not stop taking ODEFSEY without first talking to your healthcare provider, as they will need to monitor your health.

Who should not take ODEFSEY?

Do not take ODEFSEY if you take:

  • Certain prescription medicines for other conditions. It is important to ask your healthcare provider or pharmacist about medicines that should not be taken with ODEFSEY. Do not start a new medicine without telling your healthcare provider.
  • The herbal supplement St. John’s wort.
  • Any other medicines to treat HIV-1 infection.

What are the other possible side effects of ODEFSEY?

Serious side effects of ODEFSEY may also include:

  • Severe skin rash and allergic reactions. Skin rash is a common side effect of ODEFSEY. Call your healthcare provider right away if you get a rash, as some rashes and allergic reactions may need to be treated in a hospital. Stop taking ODEFSEY and get medical help right away if you get a rash with any of the following symptoms: fever, skin blisters, mouth sores, redness or swelling of the eyes (conjunctivitis), swelling of the face, lips, mouth, or throat, trouble breathing or swallowing, pain on the right side of the stomach (abdominal) area, and/or dark “tea colored” urine.
  • Depression or mood changes. Tell your healthcare provider right away if you: feel sad or hopeless, feel anxious or restless, have thoughts of hurting yourself (suicide) or have tried to hurt yourself.
  • Changes in liver enzymes. People who have had hepatitis B or C or who have certain liver enzyme changes may have a higher risk for new or worse liver problems while taking ODEFSEY. Liver problems can also happen in people who have not had liver disease. Your healthcare provider may do tests to check your liver enzymes before and during treatment with ODEFSEY.
  • Changes in your immune system. Your immune system may get stronger and begin to fight infections. Tell your healthcare provider if you have any new symptoms after you start taking ODEFSEY.
  • Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. Your healthcare provider may tell you to stop taking ODEFSEY if you develop new or worse kidney problems.
  • Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat.
  • Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain.
  • Bone problems, such as bone pain, softening, or thinning, which may lead to fractures. Your healthcare provider may do tests to check your bones.

The most common side effects of rilpivirine, one of the medicines in ODEFSEY, are depression, trouble sleeping (insomnia), and headache.
The most common side effect of emtricitabine and tenofovir alafenamide, two of the medicines in ODEFSEY, is nausea.
Tell your healthcare provider if you have any side effects that bother you or do not go away.

What should I tell my healthcare provider before taking ODEFSEY?

  • All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney, bone, mental health (depression or suicidal thoughts), or liver problems, including hepatitis virus infection.
  • All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Other medicines may affect how ODEFSEY works. Keep a list of all your medicines and show it to your healthcare provider and pharmacist. Ask your healthcare provider if it is safe to take ODEFSEY with all of your other medicines.
  • If you are pregnant or plan to become pregnant. It is not known if ODEFSEY can harm your unborn baby. Tell your healthcare provider if you become pregnant while taking ODEFSEY.
  • If you are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed. HIV-1 can be passed to the baby in breast milk.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call 1-800-FDA-1088.1-800-FDA-1088.

Please click here for full Prescribing Information, including Patient Information with important warnings for ODEFSEY.

Please click for full Prescribing Information for ODEFSEY and DESCOVY, including Patient Information with important warnings.

ODEFSEY contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide) and EDURANT (rilpivirine).

GENVOYA contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide), VITEKTA (elvitegravir), and TYBOST (cobicistat).
ODEFSEY contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide) and EDURANT (rilpivirine).
DESCOVY contains tenofovir alafenamide plus the medicine in EMTRIVA (emtricitabine).
STRIBILD contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate), VITEKTA (elvitegravir), and TYBOST (cobicistat).
COMPLERA contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate) and EDURANT (rilpivirine).
TRUVADA contains the medicines in EMTRIVA (emtricitabine) and VIREAD (tenofovir disoproxil fumarate).

 

See full Prescribing Information for COMPLERA, DESCOVY, EMTRIVA, GENVOYA, ODEFSEY, STRIBILD, TRUVADA, TYBOST, VIREAD, and VITEKTA,
including Patient Information with important warnings.

  SWIPE FOR OPTIONS  

APPROVED 2016

WHAT IS DESCOVY®?

DESCOVY is a prescription medicine that is used together with other HIV-1 medicines to treat HIV-1 in people 12 years and older. DESCOVY is not for use to help reduce the risk of getting HIV-1 infection. DESCOVY combines 2 medicines into 1 pill taken once a day. Because DESCOVY by itself is not a complete treatment for HIV-1, it must be used together with other HIV-1 medicines.

DESCOVY does not cure HIV-1 infection or AIDS. To control HIV-1 infection and decrease HIV-related illnesses, you must keep taking DESCOVY. Ask your healthcare provider if you have questions about how to reduce the risk of passing HIV-1 to others. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them.

IMPORTANT SAFETY INFORMATION FOR DESCOVY

What is the most important information I should know about DESCOVY?

DESCOVY may cause serious side effects:

  • Worsening of hepatitis B (HBV) infection. DESCOVY is not approved to treat HBV. If you have both HIV-1 and HBV and stop taking DESCOVY, your HBV may suddenly get worse. Do not stop taking DESCOVY without first talking to your healthcare provider, as they will need to monitor your health.

What are the other possible side effects of DESCOVY?

Serious side effects of DESCOVY may also include:

  • Changes in your immune system. Your immune system may get stronger and begin to fight infections. Tell your healthcare provider if you have any new symptoms after you start taking DESCOVY.
  • Kidney problems, including kidney failure. Your healthcare provider should do blood and urine tests to check your kidneys. Your healthcare provider may tell you to stop taking DESCOVY if you develop new or worse kidney problems.
  • Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat.
  • Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain.
  • Bone problems, such as bone pain, softening, or thinning, which may lead to fractures. Your healthcare provider may do tests to check your bones.

The most common side effect of DESCOVY is nausea. Tell your healthcare provider if you have any side effects that bother you or don’t go away.

What should I tell my healthcare provider before taking DESCOVY?

  • All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney, bone, or liver problems, including hepatitis virus infection.
  • All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Other medicines may affect how DESCOVY works. Keep a list of all your medicines and show it to your healthcare provider and pharmacist. Ask your healthcare provider if it is safe to take DESCOVY with all of your other medicines.
  • If you are pregnant or plan to become pregnant. It is not known if DESCOVY can harm your unborn baby. Tell your healthcare provider if you become pregnant while taking DESCOVY.
  • If you are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed. HIV-1 can be passed to the baby in breast milk.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call 1-800-FDA-1088.1-800-FDA-1088.

Please click here for full Prescribing Information, including Patient Information with important warnings for DESCOVY.

Please click for full Prescribing Information for DESCOVY and EMTRIVA, including Patient Information with important warnings.

DESCOVY contains tenofovir alafenamide plus the medicine in EMTRIVA (emtricitabine).

GENVOYA contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide), VITEKTA (elvitegravir), and TYBOST (cobicistat).
ODEFSEY contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide) and EDURANT (rilpivirine).
DESCOVY contains tenofovir alafenamide plus the medicine in EMTRIVA (emtricitabine).
STRIBILD contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate), VITEKTA (elvitegravir), and TYBOST (cobicistat).
COMPLERA contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate) and EDURANT (rilpivirine).
TRUVADA contains the medicines in EMTRIVA (emtricitabine) and VIREAD (tenofovir disoproxil fumarate).

 

See full Prescribing Information for COMPLERA, DESCOVY, EMTRIVA, GENVOYA, ODEFSEY, STRIBILD, TRUVADA, TYBOST, VIREAD, and VITEKTA,
including Patient Information with important warnings.

  SWIPE FOR OPTIONS  

APPROVED 2012

WHAT IS STRIBILD®?

STRIBILD is a prescription medicine used to treat HIV-1 in people 12 years and older who weigh at least 77 pounds. It can either be used in people who are starting HIV-1 treatment and have never taken HIV-1 medicines before, or in people who are replacing their current HIV-1 medicines and whose healthcare provider determines that they meet certain requirements. These include having an undetectable viral load (less than 50 copies/mL of virus in their blood) for 6 months or more on their current HIV-1 treatment. STRIBILD combines 4 medicines into 1 pill to be taken once a day with food. STRIBILD is a complete single tablet regimen and should not be used with other HIV-1 medicines.

STRIBILD does not cure HIV-1 infection or AIDS. To control HIV-1 infection and decrease HIV-related illnesses, you must keep taking STRIBILD. Ask your healthcare provider if you have questions about how to reduce the risk of passing HIV-1 to others. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them.

IMPORTANT SAFETY INFORMATION FOR STRIBILD

What is the most important information I should know about STRIBILD?

STRIBILD can cause serious side effects:

  • Worsening of hepatitis B (HBV) infection. STRIBILD is not approved for the treatment of HBV. If you have both HIV-1 and HBV and stop taking STRIBILD, your HBV may suddenly get worse. Do not stop taking STRIBILD without first talking to your healthcare provider, as they will need to monitor your health.

Who should not take STRIBILD?

Do not take STRIBILD if you take:

  • Certain prescription medicines for other conditions. It is important to ask your healthcare provider or pharmacist about medicines that should not be taken with STRIBILD. Do not start a new medicine without telling your healthcare provider.
  • The herbal supplement St. John’s wort.
  • Any other medicines to treat HIV-1 infection, or the medicine adefovir (Hepsera®).

What are the other possible side effects of STRIBILD?

Serious side effects of STRIBILD may also include:

  • New or worse kidney problems, including kidney failure. Your healthcare provider should do regular blood and urine tests to check your kidneys before and during treatment with STRIBILD. If you develop kidney problems, your healthcare provider may tell you to stop taking STRIBILD.
  • Too much lactic acid in your blood (lactic acidosis, which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat.
  • Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain.
  • Bone problems, including bone pain or bones getting soft or thin, which may lead to fractures. Your healthcare provider may do tests to check your bones.
  • Changes in your immune system. Your immune system may get stronger and begin to fight infections. Tell your healthcare provider if you have any new symptoms after you start taking STRIBILD.

The most common side effects of STRIBILD include nausea and diarrhea. Tell your healthcare provider if you have any side effects that bother you or don’t go away.

What should I tell my healthcare provider before taking STRIBILD?

  • All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney, bone, or liver problems, including hepatitis virus infection.
  • All the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. STRIBILD may affect the way other medicines work, and other medicines may affect how STRIBILD works. Keep a list of all your medicines and show it to your healthcare provider and pharmacist. Do not start any new medicines while taking STRIBILD without first talking with your healthcare provider.
  • If you take antacids. Take antacids at least 2 hours before or after you take STRIBILD.
  • If you are pregnant or plan to become pregnant. It is not known if STRIBILD can harm your unborn baby. Tell your healthcare provider if you become pregnant while taking STRIBILD.
  • If you are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed. HIV-1 can be passed to the baby in breast milk.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call 1-800-FDA-1088.1-800-FDA-1088.

Please click for full Prescribing Information for STRIBILD, including Patient Information with important warnings.

Please click for full Prescribing Information for STRIBILD, TRUVADA, TYBOST, and VITEKTA, including Patient Information with important warnings.

STRIBILD contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate), TYBOST (cobicistat), and VITEKTA (elvitegravir).

GENVOYA contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide), VITEKTA (elvitegravir), and TYBOST (cobicistat).
ODEFSEY contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide) and EDURANT (rilpivirine).
DESCOVY contains tenofovir alafenamide plus the medicine in EMTRIVA (emtricitabine).
STRIBILD contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate), VITEKTA (elvitegravir), and TYBOST (cobicistat).
COMPLERA contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate) and EDURANT (rilpivirine).
TRUVADA contains the medicines in EMTRIVA (emtricitabine) and VIREAD (tenofovir disoproxil fumarate).

 

See full Prescribing Information for COMPLERA, DESCOVY, EMTRIVA, GENVOYA, ODEFSEY, STRIBILD, TRUVADA, TYBOST, VIREAD, and VITEKTA,
including Patient Information with important warnings.

  SWIPE FOR OPTIONS  

APPROVED 2011

WHAT IS COMPLERA®?

COMPLERA is a prescription medicine used to treat HIV-1 in people 12 years and older. It can be used in people who have never taken HIV-1 medicines before, and who have an amount of HIV-1 in their blood (“viral load”) that is no more than 100,000 copies/mL. It can also replace current HIV-1 medicines for some people who have an undetectable viral load (less than 50 copies/mL) and whose healthcare provider determines that they meet certain other requirements. COMPLERA combines 3 medicines into 1 pill taken once a day with food. COMPLERA is a complete HIV-1 treatment and should not be used with other HIV-1 medicines.

COMPLERA does not cure HIV-1 infection or AIDS. To control HIV-1 infection and decrease HIV-related illnesses, you must keep taking COMPLERA. Ask your healthcare provider if you have questions about how to reduce the risk of passing HIV-1 to others. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them.

IMPORTANT SAFETY INFORMATION FOR COMPLERA

What is the most important information I should know about COMPLERA?

COMPLERA can cause serious side effects:

  • Worsening of hepatitis B (HBV) infection. COMPLERA is not approved to treat HBV. If you have both HIV-1 and HBV and stop taking COMPLERA, your HBV may suddenly get worse. Do not stop taking COMPLERA without first talking to your healthcare provider, as they will need to monitor your health.

Who should not take COMPLERA?

Do not take COMPLERA if you take:

  • Certain prescription medicines for other conditions. It is important to ask your healthcare provider or pharmacist about medicines that should not be taken with COMPLERA. Do not start a new medicine without telling your healthcare provider.
  • The herbal supplement St. John’s wort.
  • Other HIV-1 medicines unless recommended by your healthcare provider.

What are the other possible side effects of COMPLERA?

Serious side effects of COMPLERA may also include:

  • Severe skin rash and allergic reactions. Call your healthcare provider right away if you get a rash. Some rashes and allergic reactions may need to be treated in a hospital. Stop taking COMPLERA and get medical help right away if you get a rash with any of the following symptoms: fever, skin blisters, mouth sores, redness or swelling of the eyes (conjunctivitis), swelling of the face, lips, mouth, tongue or throat, trouble breathing or swallowing, pain on the right side of the stomach (abdominal) area, and/or dark or “tea-colored” urine.
  • New or worse kidney problems, including kidney failure. Your healthcare provider should do blood tests to check your kidneys before starting treatment with COMPLERA. If you have had kidney problems, or take other medicines that may cause kidney problems, your healthcare provider may also check your kidneys during treatment with COMPLERA.
  • Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat.
  • Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain.
  • Depression or mood changes. Tell your healthcare provider right away if you have any of the following symptoms: feeling sad or hopeless, feeling anxious or restless, have thoughts of hurting yourself (suicide) or have tried to hurt yourself.
  • Changes in liver enzymes. People who have had hepatitis B or C, or who have had changes in their liver function tests in the past may have an increased risk for liver problems while taking COMPLERA. Some people without prior liver disease may also be at risk. Your healthcare provider may do tests to check your liver enzymes before and during treatment with COMPLERA.
  • Bone problems, including bone pain or bones getting soft or thin, which may lead to fractures. Your healthcare provider may do tests to check your bones.
  • Changes in your immune system. Your immune system may get stronger and begin to fight infections. Tell your healthcare provider if you have any new symptoms after you start taking COMPLERA.

The most common side effects of rilpivirine, one of the medicines in COMPLERA, include depression, trouble sleeping, and headache.
The most common side effects of emtricitabine and tenofovir disoproxil fumarate, two of the medicines in COMPLERA, include diarrhea, nausea, tiredness, headache, dizziness, depression, trouble sleeping, abnormal dreams, and rash.
Tell your healthcare provider if you have any side effects that bother you or do not go away.

What should I tell my healthcare provider before taking COMPLERA?

  • All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney, mental health, bone, or liver problems, including hepatitis virus infection.
  • All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Other medicines may affect how COMPLERA works. Keep a list of all your medicines and show it to your healthcare provider and pharmacist. Ask your healthcare provider if it is safe to take COMPLERA with all of your other medicines.
  • If you take antacids. Take antacids at least 2 hours before or at least 4 hours after you take COMPLERA.
  • If you take stomach acid blockers. Take acid blockers at least 12 hours before or at least 4 hours after you take COMPLERA. Ask your healthcare provider if your acid blocker is okay to take, as some acid blockers should never be taken with COMPLERA.
  • If you are pregnant or plan to become pregnant. It is not known if COMPLERA can harm your unborn baby. Tell your healthcare provider if you become pregnant while taking COMPLERA.
  • If you are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed. HIV-1 can be passed to the baby in breast milk.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call 1-800-FDA-1088.1-800-FDA-1088.

Please click for full Prescribing Information for COMPLERA and TRUVADA, including Patient Information with important warnings.

COMPLERA contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate) and EDURANT (rilpivirine).

GENVOYA contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide), VITEKTA (elvitegravir), and TYBOST (cobicistat).
ODEFSEY contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide) and EDURANT (rilpivirine).
DESCOVY contains tenofovir alafenamide plus the medicine in EMTRIVA (emtricitabine).
STRIBILD contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate), VITEKTA (elvitegravir), and TYBOST (cobicistat).
COMPLERA contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate) and EDURANT (rilpivirine).
TRUVADA contains the medicines in EMTRIVA (emtricitabine) and VIREAD (tenofovir disoproxil fumarate).

 

See full Prescribing Information for COMPLERA, DESCOVY, EMTRIVA, GENVOYA, ODEFSEY, STRIBILD, TRUVADA, TYBOST, VIREAD, and VITEKTA,
including Patient Information with important warnings.

  SWIPE FOR OPTIONS

APPROVED 2004

WHAT IS TRUVADA®?

TRUVADA is a prescription medicine that is used to treat HIV-1 infection in people who weigh at least 35 kg (77 pounds). Because TRUVADA by itself is not a complete treatment for HIV-1, it must be used together with other HIV-1 medicines.

TRUVADA does not cure HIV-1 infection or AIDS. Ask your healthcare provider if you have questions about how to prevent getting HIV-1 or passing HIV-1 to others. Always practice safer sex and use condoms to lower the chance of sexual contact with body fluids. Never reuse or share needles or other items that have body fluids on them. If you are taking TRUVADA with other HIV-1 medicines to treat HIV-1, you must keep taking TRUVADA to control HIV-1 infection and decrease HIV-1 related illnesses.

IMPORTANT SAFETY INFORMATION FOR TRUVADA

What is the most important information I should know about TRUVADA?

TRUVADA can cause serious side effects:

  • Worsening of hepatitis B (HBV) infection. TRUVADA is not approved to treat HBV. If you have HBV and stop taking TRUVADA, your HBV may suddenly get worse. Do not stop taking TRUVADA without first talking to your healthcare provider, as they will need to monitor your health.

Who should not take TRUVADA?

Do not take TRUVADA if you also take:

  • Medicines containing any of the same active ingredients as found in TRUVADA.
  • Certain other medicines used to treat HIV or hepatitis B infection.

What are the other possible side effects of TRUVADA?

Serious side effects of TRUVADA may also include:

  • Kidney problems, including kidney failure. Your healthcare provider may do blood tests to check your kidneys before and during treatment with TRUVADA. If you develop kidney problems, your healthcare provider may tell you to stop taking TRUVADA.
  • Too much lactic acid in your blood (lactic acidosis), which is a serious but rare medical emergency that can lead to death. Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat.
  • Severe liver problems, which in rare cases can lead to death. Tell your healthcare provider right away if you get these symptoms: skin or the white part of your eyes turns yellow, dark “tea-colored” urine, light-colored stools, loss of appetite for several days or longer, nausea, or stomach-area pain.
  • Bone problems, including bone pain, softening, or thinning, which may lead to fractures. Your healthcare provider may do tests to check your bones.
  • Changes in your immune system. If you have HIV-1 infection and start taking HIV-1 medicines, your immune system may get stronger and begin to fight infections. This may cause minor symptoms such as fever, but can also lead to serious problems. Tell your healthcare provider if you have any new symptoms after you start taking TRUVADA.

The most common side effects in people taking TRUVADA to treat HIV-1 infection include: diarrhea, nausea, tiredness, headache, dizziness, depression, problems sleeping, abnormal dreams, and rash. Tell your healthcare provider if you have any side effects that bother you or don't go away.

What should I tell my healthcare provider before taking TRUVADA?

  • All your health problems. Be sure to tell your healthcare provider if you have or have had any kidney, bone, or liver problems, including hepatitis.
  • If you are pregnant or plan to become pregnant. It is not known if TRUVADA can harm your unborn baby. Tell your healthcare provider if you become pregnant while taking TRUVADA.
  • If you are breastfeeding (nursing) or plan to breastfeed. Do not breastfeed. HIV can be passed to the baby in breast milk.
  • All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. TRUVADA may interact with other medicines. Keep a list of all your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.
  • If you take certain other medicines with TRUVADA, your healthcare provider may need to check you more often or change your dose. These medicines include certain medicines used to treat HIV and hepatitis C infection.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch, or call 1-800-FDA-1088.1-800-FDA-1088.

Please click for full Prescribing Information for TRUVADA, including Patient Information with important warnings.

Please click for full Prescribing Information for EMTRIVA, TRUVADA, and VIREAD, including Patient Information with important warnings.

TRUVADA contains the medicines in EMTRIVA (emtricitabine) and VIREAD (tenofovir disoproxil fumarate).

GENVOYA contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide), VITEKTA (elvitegravir), and TYBOST (cobicistat).
ODEFSEY contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide) and EDURANT (rilpivirine).
DESCOVY contains tenofovir alafenamide plus the medicine in EMTRIVA (emtricitabine).
STRIBILD contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate), VITEKTA (elvitegravir), and TYBOST (cobicistat).
COMPLERA contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate) and EDURANT (rilpivirine).
TRUVADA contains the medicines in EMTRIVA (emtricitabine) and VIREAD (tenofovir disoproxil fumarate).

 

See full Prescribing Information for COMPLERA, DESCOVY, EMTRIVA, GENVOYA, ODEFSEY, STRIBILD, TRUVADA, TYBOST, VIREAD, and VITEKTA,
including Patient Information with important warnings.

GENVOYA contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide), VITEKTA (elvitegravir), and TYBOST (cobicistat).
ODEFSEY contains the medicines in DESCOVY (emtricitabine and tenofovir alafenamide) and EDURANT (rilpivirine).
DESCOVY contains tenofovir alafenamide plus the medicine in EMTRIVA (emtricitabine).
STRIBILD contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate), VITEKTA (elvitegravir), and TYBOST (cobicistat).
COMPLERA contains the medicines in TRUVADA (emtricitabine and tenofovir disoproxil fumarate) and EDURANT (rilpivirine).
TRUVADA contains the medicines in EMTRIVA (emtricitabine) and VIREAD (tenofovir disoproxil fumarate).

 

See full Prescribing Information for COMPLERA, DESCOVY, EMTRIVA, GENVOYA, ODEFSEY, STRIBILD, TRUVADA, TYBOST, VIREAD, and VITEKTA,
including Patient Information with important warnings.

IMPORTANT SAFETY INFORMATION

Click or scroll down to see Important Safety Information, including an important warning on worsening of hepatitis B infection.